Sunday, October 1, 2023
manilastandard.net
ADVERTISEMENT
  • About
  • News
    • Top Stories
    • National
    • World News
    • Pinoy Abroad
    • Features
  • Opinion
    • Editorial
    • Columns
    • Soundbytes
  • LGUs
    • NCR
    • Luzon
    • Visayas
    • Mindanao
  • Business
    • Corporate
    • Economy & Trade
    • Stocks
    • Money
    • Agri & Mining
    • Power & Tech
    • IT & Telecom
  • Sports
    • Basketball
    • Volleyball
    • Fightsports
    • Active
    • Sports Plus
    • One Championship
    • Columns
  • Entertainment
    • TV & Movies
    • Celebrity Profiles
    • Music & Concerts
    • Digital Media
    • Columns
  • Lifestyle
    • Food
    • Culture & Media
    • Fashion
    • Health and Home
    • Leisure
    • Shopping
    • Columns
    • Young Life
  • Special Pages
    • Pets
    • Tech
      • Gadgets
      • Computers
      • Business
      • Tech Plus
    • On the Road
      • Sedan
      • SUV
      • Truck
      • Bike
      • Accessories
      • Motoring Plus
      • Commuter’s Corner
    • Home & Design
      • Residential
      • Commercial
      • Construction
      • Interior
    • Spotlight
    • Cravings
    • Environment & Sustainability
    • Agriculture
    • Pop.Life
      • Newsmakers
      • Hangouts
      • A-Pop
      • Post Its
      • Performances
      • Malls & Bazaars
      • Hobbies & Collections
    • Events
      • Seminars
      • Exhibits
      • Community
    • Biyahero
      • Travel Features
      • Travel Reels
      • Travel Logs
    • Gallery
      • Photos
      • Videos
  • Advertise with Us
No Result
View All Result
  • About
  • News
    • Top Stories
    • National
    • World News
    • Pinoy Abroad
    • Features
  • Opinion
    • Editorial
    • Columns
    • Soundbytes
  • LGUs
    • NCR
    • Luzon
    • Visayas
    • Mindanao
  • Business
    • Corporate
    • Economy & Trade
    • Stocks
    • Money
    • Agri & Mining
    • Power & Tech
    • IT & Telecom
  • Sports
    • Basketball
    • Volleyball
    • Fightsports
    • Active
    • Sports Plus
    • One Championship
    • Columns
  • Entertainment
    • TV & Movies
    • Celebrity Profiles
    • Music & Concerts
    • Digital Media
    • Columns
  • Lifestyle
    • Food
    • Culture & Media
    • Fashion
    • Health and Home
    • Leisure
    • Shopping
    • Columns
    • Young Life
  • Special Pages
    • Pets
    • Tech
      • Gadgets
      • Computers
      • Business
      • Tech Plus
    • On the Road
      • Sedan
      • SUV
      • Truck
      • Bike
      • Accessories
      • Motoring Plus
      • Commuter’s Corner
    • Home & Design
      • Residential
      • Commercial
      • Construction
      • Interior
    • Spotlight
    • Cravings
    • Environment & Sustainability
    • Agriculture
    • Pop.Life
      • Newsmakers
      • Hangouts
      • A-Pop
      • Post Its
      • Performances
      • Malls & Bazaars
      • Hobbies & Collections
    • Events
      • Seminars
      • Exhibits
      • Community
    • Biyahero
      • Travel Features
      • Travel Reels
      • Travel Logs
    • Gallery
      • Photos
      • Videos
  • Advertise with Us
No Result
View All Result
manilastandard.net
No Result
View All Result
Home News Coronavirus 2019

WHO ‘strongly recommends’ Pfizer’s Covid pill

AFPbyAFP
April 22, 2022, 7:21 am
in Coronavirus 2019, World News
Reading Time: 3 mins read
A A
Share on FacebookShare on TwitterShare on Email

The World Health Organization said Friday it “strongly recommended” Pfizer’s Covid-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalisation.

However the UN agency warned it was “extremely concerned” that the inequality in access seen with Covid vaccines would again leave low- and middle-income countries “pushed to the end of the queue”.

US pharma giant Pfizer’s combination of nirmatrelvir and ritonavir was the “superior choice” of treatment for unvaccinated, elderly or immunocompromised people with Covid, the WHO’s experts said in the BMJ medical journal.

For the same patients, the WHO also made a “conditional (weak) recommendation” of the antiviral drug remdesivir made by US biotech firm Gilead — which it had previously recommended against.

The WHO recommended Paxlovid over remdesivir, as well as over Merck’s molnupiravir pill and monoclonal antibodies.

Pfizer’s oral treatment prevents hospitalisation more than the “available alternatives, has fewer concerns with respects to harms than molnupiravir, and is easier to administer than intravenous remdesivir and antibodies,” the WHO’s experts said.

The new recommendation was based on the findings of two trials involving almost 3,100 patients which showed that Paxlovid reduced the risk of hospital admission by 85 percent.

The trials also “suggested no important difference in mortality” and “little or no risk of adverse effects leading to drug discontinuation”. 

The recommendation applies to people over the age of 18, but not to pregnant or breastfeeding women.

It also does not apply to patients with a low risk of complications from the disease, because the benefit would be minimal.

The WHO’s experts also declined to give an opinion for patients with severe forms of the disease, due to a lack of data.

– Limitations and inequities –

The WHO stressed the limitations of such antiviral treatments. 

“The medicine can only be administered while the disease is at its early stages,” they said.

This means the patients must quickly test positive and be prescribed the pill by a doctor — all of which can pose obstacles for low- and middle-income countries, the WHO said.

Yet Covid pills have been seen as a potentially huge step in ending the pandemic as they can be taken at home, rather than in hospital.

Patients must start taking their Paxlovid pills within five days of the onset of symptoms — the course then lasts five days.

Remdesivir can be taken within seven days of symptoms setting in, but it is administered intravenously over three days.

– Questions about cost –

The WHO called on Pfizer to “make its pricing and deals more transparent” for Paxlovid.

Lisa Hedman, the WHO’s senior advisor on access to medicines, said that radio station NPR reported a full course of Paxlovid costs $530 in the United States. Another source unconfirmed by WHO gave the price of $250 in an upper-middle income country.

Remdesivir meanwhile costs $520, Hedman said, but generic versions made by companies in India sell for $53-$64. 

There is also a question mark over whether the virus could build resistance to these treatments.

But earlier this month Pfizer CEO Albert Bourla predicted a bright future for treatments like Paxlovid as people grow tired of getting further booster vaccinations.

Coming under fire for prioritising wealthy countries with its vaccine, Pfizer has agreed to allow some generic drugmakers around the world to make cheaper versions of Paxlovid under a UN-backed scheme. 

But on Friday the WHO “strongly recommended” that Pfizer let more generic manufacturers produce the drug and “make it available faster at affordable prices”.

Tags: corona virusPfizerWHO
ADVERTISEMENT
AFP

AFP

Related Posts

US government hours from shutdown, funding chaos

byAFP
September 30, 2023, 10:25 pm
0
8
US hiking visa fees to $185 starting May 30

WASHINGTON­—The US government on Saturday was hours from shutting down after the far right of the Republican Party scuppered final...

Read more

Israel, Saudi moving toward deal, says US

byAFP
September 30, 2023, 10:20 pm
0
8
Emotional Biden mourns on anniversary of Uvalde school massacre

WASHINGTON—Israel and Saudi Arabia are moving towards the outline of a historic US-brokered deal to normalize relations after decades of...

Read more

New York flooded by heavy rains, subway partly paralyzed

byAFP
September 30, 2023, 10:20 pm
0
8
New York flooded by heavy rains, subway partly paralyzed

New York, United States—Heavy rains overnight in the northeastern United States left parts of New York under water on Friday,...

Read more

UK to push back on ‘anti-car measures’

byAFP
September 30, 2023, 10:15 pm
0
8
Southwoods nails Seniors’ Fil golf crown

LONDON—Britain’s Conservative government on Friday announced new plans to “support drivers” and push back on “anti-car measures” as some opposition-led...

Read more

Lula undergoes hip surgery okay

byAFP
September 30, 2023, 10:10 pm
0
8
Colonial-era walkway falls into river: India bridge collapse kills more than 130

Brasília, Brazil—Brazil’s President Luiz Inacio Lula da Silva was awake and recovering from hip surgery on Friday, which his doctor...

Read more

Kosovo on edge as deadly clashes unease

byAFP
September 30, 2023, 10:05 pm
0
8
Southwoods nails Seniors’ Fil golf crown

PRISTINA, Kosovo -- Nearly a week after deadly clashes in Kosovo triggered one of the gravest escalations in the former...

Read more

Print Edition

View More

Recent Posts

  • UAAP Season 86 opens
  • (no title)
  • A day for animals
  • Marcos sets P12.7B aid for 2.3M rice farmers
  • ‘Chinese activities destroyed 500 hectares of WPS corals’
  • Obiena claims first PH gold in Asian Games
  • Petron raising LPG tank price by P3.75/kl on Oct. 1
  • Gilas falls to Jordan; Qatar, Iran stand in way to semis

Advertisement

Latest News

Obiena claims first PH gold in Asian Games

byManila Standard
October 1, 2023, 12:20 am
0
8
Obiena claims first PH gold in Asian Games

HANGZHOU, China—Ernest John Obiena claimed the Philippines’ first gold medal in the 19th Asian Games on Saturday, clearing 5.90 meters...

Read more

Petron raising LPG tank price by P3.75/kl on Oct. 1

byAlena Mae S. Flores
October 1, 2023, 12:10 am
0
8
LPG price rollback: Petron sets big-time cuts

Petron Corp. is raising the price of its liquefied petroleum gas (LPG) by P3.75 per kilo, equivalent to P41.25 per...

Read more

Gilas falls to Jordan; Qatar, Iran stand in way to semis

byManila Standard Sports
October 1, 2023, 12:10 am
0
8
Gilas falls to Jordan; Qatar, Iran stand in way to semis

  JuneMar Fajardo HANGZHOU — Jordan and Rondae Hollis-Jefferson ended Gilas Pilipinas’ winning run in the 19th Asian Games on...

Read more

Gibo plans reserve forces revamp

byCharles Dantes
October 1, 2023, 12:00 am
0
8
Environmental activists may face perjury raps — solon

Defense Secretary Gilbert Teodoro on Saturday expressed his intention to revise the current reserve forces paradigm structure of the Armed...

Read more

Canadian ship, Pinoy crew

byNorman Cruzand1 others
September 30, 2023, 11:50 pm
0
8
‘Jenny’ seen becoming typhoon by Monday

His Majesty’s Canadian Ship (HMCS) Vancouver docks at Pier 15 in Manila South Harbor for a port call on Saturday....

Read more

Advertisement

ADVERTISEMENT
Facebook Twitter Instagram Youtube

ABOUT US

Manila Standard

Manila Standard website (manilastandard.net), launched in August 2002, extends the newspaper’s reach beyond its traditional readers and makes its brand of Philippine news and opinion available to a much wider and geographically diverse readership here and overseas.

Digital Edition

In tone and content, the online edition mirrors the editorial thrust of the newspaper. While hewing to the traditional precepts of fairness and objectivity, MS believes the news of the day need not be staid, overly long or dry. Stories are succinct, readable and written in a lively style that has become a hallmark of the newspaper.

Download – Today’s Paper

Search

No Result
View All Result

6th Floor Universal Re Bldg., 106 Paseo De Roxas cor. Perea Street, Legaspi Village, 1226 Makati City Philippines

Trunklines: 832-5554, 832-5556, 832-5558

© 2021 Manila Standard - Designed and Developed by Neitiviti Studios.

No Result
View All Result
  • About
  • News
    • Top Stories
    • National
    • World News
    • Pinoy Abroad
    • Features
  • Opinion
    • Editorial
    • Columns
    • Soundbytes
  • LGUs
    • NCR
    • Luzon
    • Visayas
    • Mindanao
  • Business
    • Corporate
    • Economy & Trade
    • Stocks
    • Money
    • Agri & Mining
    • Power & Tech
    • IT & Telecom
  • Sports
    • Basketball
    • Volleyball
    • Fightsports
    • Active
    • Sports Plus
    • One Championship
    • Columns
  • Entertainment
    • TV & Movies
    • Celebrity Profiles
    • Music & Concerts
    • Digital Media
    • Columns
  • Lifestyle
    • Food
    • Culture & Media
    • Fashion
    • Health and Home
    • Leisure
    • Shopping
    • Columns
    • Young Life
  • Pets
  • Tech
    • Gadgets
    • Computers
    • Business
    • Tech Plus
  • ON THE ROAD
    • Sedan
    • SUV
    • Truck
    • Bike
    • Accessories
    • Motoring Plus
    • Commuter’s Corner
  • Home & Design
    • Residential
    • Commercial
    • Construction
    • Interior
  • Spotlight
  • Cravings
  • Environment & Sustainability
  • Agriculture
  • Pop.Life
    • Newsmakers
    • Hangouts
    • A-Pop
    • Post Its
    • Performances
    • Malls & Bazaars
    • Hobbies & Collections
  • Events
    • Seminars
    • Exhibits
    • Community
  • Biyahero
    • Travel Features
    • Travel Reels
    • Travel Logs
  • Gallery
    • Photos
    • Videos
  • Advertise with Us

© 2021 Manila Standard - Designed and Developed by Neitiviti Studios.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Install Manila Standard Web App

Install App